Biologically Based Methods for Cancer Risk Assessment: NATO Science Series A:, cartea 159
Editat de Curtis Travisen Limba Engleză Paperback – 30 apr 2013
Din seria NATO Science Series A:
- 15% Preț: 656.58 lei
- 15% Preț: 655.13 lei
- 15% Preț: 678.35 lei
- Preț: 397.38 lei
- 5% Preț: 377.87 lei
- Preț: 397.76 lei
- 18% Preț: 1232.41 lei
- 5% Preț: 731.64 lei
- Preț: 413.15 lei
- 15% Preț: 649.22 lei
- 5% Preț: 369.45 lei
- Preț: 407.56 lei
- 5% Preț: 2162.19 lei
- Preț: 407.39 lei
- Preț: 396.40 lei
- 15% Preț: 663.93 lei
- Preț: 387.38 lei
- Preț: 393.13 lei
- Preț: 398.35 lei
- Preț: 401.24 lei
- 15% Preț: 678.81 lei
- Preț: 395.09 lei
- 18% Preț: 952.40 lei
- 15% Preț: 654.43 lei
- Preț: 402.00 lei
- Preț: 401.24 lei
- 15% Preț: 655.27 lei
- Preț: 394.71 lei
- Preț: 384.48 lei
- 5% Preț: 395.61 lei
- 5% Preț: 1421.57 lei
- 15% Preț: 651.34 lei
- Preț: 400.10 lei
- Preț: 386.99 lei
- 5% Preț: 386.11 lei
- Preț: 403.91 lei
- 15% Preț: 651.51 lei
- Preț: 393.90 lei
- 5% Preț: 376.43 lei
- Preț: 400.26 lei
- 5% Preț: 388.84 lei
- Preț: 400.65 lei
- 5% Preț: 740.58 lei
- 18% Preț: 1225.16 lei
- 5% Preț: 386.46 lei
- Preț: 421.82 lei
Preț: 377.52 lei
Preț vechi: 397.38 lei
-5% Nou
Puncte Express: 566
Preț estimativ în valută:
72.25€ • 74.64$ • 60.13£
72.25€ • 74.64$ • 60.13£
Carte tipărită la comandă
Livrare economică 26 martie-09 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781468456271
ISBN-10: 146845627X
Pagini: 368
Ilustrații: IX, 355 p. 54 illus.
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.64 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
ISBN-10: 146845627X
Pagini: 368
Ilustrații: IX, 355 p. 54 illus.
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.64 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Research Needs for Biologically Based Risk Assessment.- Biological Bases for Cancer Models.- Multistage Models for Cancer Risk Assessment.- Understanding Multi-Stage Carcinogenesis at the Molecular Level: Notes on Recent Progress.- The Use of Enzyme-Altered Foci for Risk Assessment of Hepatocarcinogens.- Pathogenic Interrelationship of Focal Lesions, Nodules, Adenomas and Carcinomas in the Multistage Evolution of Azaserine-Induced Rat Pancreas Carcinogenesis.- Phenotypic Cellular Changes in Multistage Carcinogenesis.- Interspecies Extrapolation of Pharmacokinetics.- Interspecies Extrapolation.- Comparative Carcinogenesis: Is There a Theoretical Approach to Inter-Species Similarity.- Biological Basis for Interspecies Extrapolations of Halogenated Solvents and of 1,3-Butadiene.- Species-Specific Inhalation Pharmacokinetics of 2-Nitropropane, Methyl Ethyl Ketone, and n-Hexane.- Promotion as a Factor in Carcinogenesis.- Overview of Promotion as a Mechanism in Carcinogenesis.- Hepatocarcinogenesis by Non-Genotoxic Compounds.- The Role of Inhibited Intercellular Communication in Carcinogenesis: Implications for Risk Assessment From Exposure to Chemicals.- Comparative Analyses of the Timing and Magnitude of Genotoxic and Nongenotoxic Cellular Effects in Urinary Bladder Carcinogenesis.- Alterations in Gene Expression in Mouse Hepatocarcinogenesis.- Screening for Carcinogenesis.- Medium-Term Bioassay Models for Environmental Carcinogens — Two — Step Liver and Multi-Organ Carcinogenesis Protocols.- The Use of Aldh Induction as a Carcinogenic Risk Marker in Comparison With Typical in Vitro Mutagenicity System.- Expression of Inducible Cytochrome P-450 mRNAs During Promotion of Expermential Chemical Hepatocarcinogenesis.- An In Vitro Approach for Interspecies ExtrapolationUsing Animal and Human Airway Epithelial Cell Culture.- Cancer Risk Assessment.- Assement of Low-Exposure Risk from Carcinogens: Implications of the Knudson-Moolgavkar Two-Critical Mutation Theory.- A Biological Data Base for Methylene Chloride Risk Assessment.- Computer Simulation of Chemical Carcinogenesis.- Determination of Carcinogen Exposure by Immunological Techniques.- Risk Estimation for Leukemogenic Drugs.- Contributors.